Negative Strand RNA Virus Replicon Technology

In an agreement with Rush University Medical Center and  the National Institutes of Health Public Health Services, Apath has exclusively in-licensed the rights to this technology.  This patented technology is available to be licensed non-exclusively to interested third parties.  For further information regarding Negative Strand RNA Virus Replicon Technology, please reference patent: PCT US2004/18783 Negative Strand RNA Virus Replicon.